Last active
March 15, 2018 02:45
-
-
Save Zhenmao/7cfd4d09a05fa869920301711cda3936 to your computer and use it in GitHub Desktop.
Bubble chart animation over time
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
{ | |
"nodes": [ | |
{ | |
"id": "ciq_company_258769", | |
"user": "Celgene Corporation", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_1271175", | |
"user": "Athenian Venture Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_214880050", | |
"user": "Glaxo Wellcome Farmaceutica, Lda", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_49068206", | |
"user": "Glaxosmithkline Investigacion Y Desarrollo, S.L.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_6699789", | |
"user": "Glaxo Wellcome Puerto Rico Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_21901", | |
"user": "Montreux Equity Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_284818", | |
"user": "Lilly Industries, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_257556714", | |
"user": "Glaxo Laboratories Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_27978054", | |
"user": "Concert Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_49701841", | |
"user": "Excel Venture Management", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "cbi_investor_Care_Capital", | |
"user": "Care Capital", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_28872662", | |
"user": "BioVision, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_99157432", | |
"user": "GlaxoSmithKline Mercury Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_23089", | |
"user": "St. Paul Venture Capital, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_320154314", | |
"user": "Glaxosmithkline Investment Services Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_141813615", | |
"user": "Atreca, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_47827786", | |
"user": "Laboratorios Stiefel Ltda.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_129137910", | |
"user": "Novartis Vaccines And Diagnostics Pty Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_286414408", | |
"user": "TVM Capital China Limited", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_255357", | |
"user": "Block Drug Company, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_424490932", | |
"user": "QVT Singapore Fund Pte. Ltd.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_27315", | |
"user": "Cytokinetics, Incorporated", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_29617", | |
"user": "Human Genome Sciences Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_156645", | |
"user": "Astex Therapeutics Limited", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "cb_agent_4b26b786-94e0-5b87-be66-923b98b173fa", | |
"user": "Undisclosed Investor", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_208908809", | |
"user": "GlaxoSmithKline SL Holdings, LLC", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_30558634", | |
"user": "GlaxoSmithKline (Israel) Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_47195264", | |
"user": "Glaxosmithkline Caribbean Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_6024858", | |
"user": "GSK Ventures", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_52035870", | |
"user": "GlaxoSmithKline plc, Asset Management Arm", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5533894", | |
"user": "GlaxoSmithKline s.a./n.v.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_47100094", | |
"user": "Smithkline Beecham Pharmaceuticals (Pty) Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_325845633", | |
"user": "GlaxoSmithKline Consumer Healthcare Holdings Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_146081846", | |
"user": "Laboratorios Viiv Healthcare Sl", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_1438809", | |
"user": "Reliant Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_28877", | |
"user": "Genentech, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_535683065", | |
"user": "Topspin Ventures", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_45015429", | |
"user": "GlaxoSmithKline Employee Trust", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_2706719", | |
"user": "Vitae Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_4119835", | |
"user": "Biotica Technology Limited", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_50880170", | |
"user": "Smithkline Beecham (Manufacturing) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_47265565", | |
"user": "Stiefel Laboratories (Maidenhead) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_29428378", | |
"user": "Chiron Behring Vaccines Private Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_422805", | |
"user": "Applied Genomic Technology Capital Funds", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_272630991", | |
"user": "Silarus Therapeutics, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_378571836", | |
"user": "Galvani Bioelectronics Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_49686157", | |
"user": "GlaxoSmithKline d.o.o. (Croatia)", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_60351109", | |
"user": "Stiefel Laboratories Pty Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_18935", | |
"user": "Atlas Venture L.P.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_204924956", | |
"user": "Valence Life Sciences", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_49409583", | |
"user": "GlaxoSmithKline Holdings Pty Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_402068695", | |
"user": "Gilde Buy-Out Fund Iii B.V.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5546439", | |
"user": "GlaxoSmithKline Services Unlimited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_26272922", | |
"user": "Inserm Transfert Initiative", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_5854125", | |
"user": "GlaxoSmithKline Consumer Healthcare Sp. z o. o.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_130339985", | |
"user": "Spectra Biomedical, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_921010", | |
"user": "Lux Capital Management", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_2213617", | |
"user": "Avera Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_278381237", | |
"user": "Glaxosmithkline (Netherlands) B.v", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_99222030", | |
"user": "ViiV Healthcare UK Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_282144849", | |
"user": "GlaxoSmithKline Consumer Private-Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_118803485", | |
"user": "Glaxosmithkline Consumer Healthcare AB", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_59409869", | |
"user": "PT Sterling Products Indonesia", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_32627703", | |
"user": "GlaxoSmithKline Chile Farmaceutica Limitada", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_50148304", | |
"user": "Glaxo S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5774635", | |
"user": "GlaxoSmithKline Consumer Healthcare S.p.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_224667815", | |
"user": "Phivco Uk Ii Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_62189146", | |
"user": "Frontier Angel Fund LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_1502364", | |
"user": "SV Health Investors, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_49493345", | |
"user": "GlaxoSmithKline Algerie S.p.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_370546945", | |
"user": "Viiv Healthcare Finance Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_12929850", | |
"user": "Beecham Portuguesa - Produtos FarmacEuticos E QuImicos, Lda", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_51737654", | |
"user": "SpringLeaf Therapeutics, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_153978400", | |
"user": "Viiv HIV Healthcare, Unipessoal, Lda", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_6435226", | |
"user": "SmithKline Beecham (Cork) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_99360147", | |
"user": "GlaxoSmithKline Insurance Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_26877974", | |
"user": "SBI Investment Co., Ltd.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_78910261", | |
"user": "Mission Bay Capital LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_53884153", | |
"user": "GSK-Gebro Consumer Healthcare GmbH", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5600343", | |
"user": "GlaxoSmithKline Brasil Ltda.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_1455350", | |
"user": "Fennec Pharmaceuticals Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_345597688", | |
"user": "Fedialis Medica S.A.S.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_20459875", | |
"user": "Auriga Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_683779", | |
"user": "Wellington Management Group LLP", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22728733", | |
"user": "Beecham Pharmaceuticals (Pte) Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5490849", | |
"user": "Glaxo Wellcome, S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_253819405", | |
"user": "H. Acquisition Corp.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_145269749", | |
"user": "Merck Retail Ventures, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_26557737", | |
"user": "Stafford Miller (Ireland) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_95039", | |
"user": "Mediphase Venture Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22396242", | |
"user": "Europharm Holding SA", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_47112257", | |
"user": "GlaxoSmithKline Holdings Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_49031336", | |
"user": "Glaxosmithkline Consumer Healthcare Gmbh", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "cbi_investor_Future_Capital", | |
"user": "Future Capital", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_304036917", | |
"user": "Adrenergics, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_26079137", | |
"user": "Vertex Pharmaceuticals (Europe) Limited", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_130691", | |
"user": "Diadexus, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_46891351", | |
"user": "Glaxosmithkline Investments Pty Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_380664276", | |
"user": "ViiV Healthcare ULC", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_24362", | |
"user": "Innoviva, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_33185", | |
"user": "Praecis Pharmaceuticals Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5472099", | |
"user": "Nomura Research Institute, Ltd.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_7911635", | |
"user": "GlaxoSmithKline Consumer Healthcare, L.P.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_216539666", | |
"user": "Stiefel Farma S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_2131884", | |
"user": "Barrier Therapeutics, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_11761481", | |
"user": "Clough Capital Partners, L.P.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_9009487", | |
"user": "Glaxosmithkline Pharmaceuticals Nigeria Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5207180", | |
"user": "Glaxosmithkline Consumer Healthcare A/S", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_379657706", | |
"user": "GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_316446473", | |
"user": "Iron Horse Therapeutics Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_6450664", | |
"user": "Glaxo Group Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_23271245", | |
"user": "GlaxoSmithKline Consumer Healthcare Sdn. Bhd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_8084393", | |
"user": "Wellcome Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_320614471", | |
"user": "Viiv Healthcare Uk (No.3) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_23021770", | |
"user": "Glaxosmithkline Pharmaceuticals (Suzhou) Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_329086899", | |
"user": "Prosensa Holding N.V.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_8890528", | |
"user": "Wellington Management, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5202913", | |
"user": "GSK Denmark A / S", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_25021820", | |
"user": "Oxford Finance LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_103375", | |
"user": "Bayer Aktiengesellschaft", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22049", | |
"user": "New Enterprise Associates", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_28703", | |
"user": "Franklin Resources, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_49493282", | |
"user": "GlaxoSmithKline d.o.o.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_12764770", | |
"user": "Groupe GlaxoSmithKline S.A.S.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_58089861", | |
"user": "Burroughs Wellcome International Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_26004239", | |
"user": "Schering Corporation", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_419225", | |
"user": "Cellzome GmbH", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_28772798", | |
"user": "Flybridge Capital Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_42163491", | |
"user": "Shin Nihon Jitsugyo Kk", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_1274157", | |
"user": "Avalon Ventures, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "cbi_investor_SBNY", | |
"user": "SBNY", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_45793878", | |
"user": "Greylock Capital Management, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_23485", | |
"user": "Three Arch Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22546705", | |
"user": "GlaxoSmithKline S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_23296306", | |
"user": "Porton Capital Limited", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_33989383", | |
"user": "GlaxoSmithKline Holdings (Americas) Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_890906", | |
"user": "Saludalia Interactiva, S.L.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "djvs_company_USVP_Management_Company_LLC", | |
"user": "USVP Management Company LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_10125054", | |
"user": "Phase4 Partners Limited", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_114130142", | |
"user": "Convergence Pharmaceuticals Limited", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_222704174", | |
"user": "Smithkline Beecham Pharmaceuticals, Pt", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_24082353", | |
"user": "GlaxoSmithKline LLC", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_213673913", | |
"user": "Glaxo Wellcome Pension Plan", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_556341", | |
"user": "Glaxosmithkline Biologicals", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "cbi_investor_Excel_Medical_Fund", | |
"user": "Excel Medical Fund", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_21299", | |
"user": "Johnson & Johnson Innovation - JJDC, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_1288232", | |
"user": "Nomura Holdings, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_732397", | |
"user": "Panacea Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_4729484", | |
"user": "Smithkline Beecham Inter-American Corporation", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_22369808", | |
"user": "SmithKline Beecham Overseas Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_280552987", | |
"user": "Glaxosmithkline Consumer Trading Services Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_112825902", | |
"user": "GlaxoSmithKline Pharmaceuticals Ukraine LLC", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_269686058", | |
"user": "GlaxoSmithKline Intellectual Property Development Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_59604353", | |
"user": "Abingworth Ventures (G.P.) Limited", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_127549", | |
"user": "BTG plc", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_45730062", | |
"user": "GlaxoSmithKline GmbH & Co. KG", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_46270636", | |
"user": "Stiefel Laboratories (U.K.) Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_62309143", | |
"user": "GlaxoSmithKline Medicine and Healthcare Products Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_29380920", | |
"user": "LFB Biotechnologies S.A.S", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_291453004", | |
"user": "Essex Woodlands-backed Rheumco, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_19099", | |
"user": "Bay City Capital LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_31236208", | |
"user": "Stiefel India Private Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_4271061", | |
"user": "Novartis Consumer Health, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_114120328", | |
"user": "Cellzome Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "djvs_company_Bay_Partners", | |
"user": "Bay Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_7918457", | |
"user": "National Comprehensive Cancer Network, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_21169", | |
"user": "InterWest Partners LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_26447872", | |
"user": "GlaxoSmithKline A.E.B.E.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_226331215", | |
"user": "Gsk D.O.O., Ljubljana", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_27368603", | |
"user": "Brookside Capital, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_99274145", | |
"user": "GlaxoSmithKline International (Luxembourg) S.A.R.L", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_115830209", | |
"user": "Cascan Gmbh & Co Kg", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "cb_agent_3328ebbd-d05a-2fe3-6a75-0eaff4808af7", | |
"user": "Ysios Capital", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5532031", | |
"user": "GlaxoSmithKline Mexico S.A. de C.V.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_317627", | |
"user": "Boston Scientific Corporation", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_53275008", | |
"user": "South East Fund Managers Limited", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5532035", | |
"user": "SmithKline Beecham S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_1380491", | |
"user": "CVRx, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_130421141", | |
"user": "Novartis Vaccines and Diagnostics AG", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_130702122", | |
"user": "ViiV Healthcare SAS", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_283095693", | |
"user": "GlaxoSmithKline Consumer Healthcare Finance Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_378762888", | |
"user": "Biovesta Ila\\u00E7lari Ltd. Sti.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_30489034", | |
"user": "GlaxoSmithKline Slovakia S.R.O.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_109320424", | |
"user": "GlaxoSmithKline (China) R&D Co., Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_22127", | |
"user": "North Bridge Venture Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22760010", | |
"user": "GlaxoSmithKline s.r.o.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_38236743", | |
"user": "Laboratorios Dermatologicos Darier, S.A. de C.V.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5844166", | |
"user": "Kyokuto Securities Co., Ltd.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_4509033", | |
"user": "Clough Limited", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_9459021", | |
"user": "Golden Helix, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_1318957", | |
"user": "Chroma Therapeutics Ltd.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_1892289", | |
"user": "iResearch Ltd.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_6021320", | |
"user": "GlaxoSmithKline-Produtos Farmaceuticos, Limitada", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_19199", | |
"user": "Vivo Capital, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_26062896", | |
"user": "SmithKline Beecham Pharma S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_22231", | |
"user": "Flagship Pioneering", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_99360544", | |
"user": "GlaxoSmithKline Puerto Rico Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_29342550", | |
"user": "GlaxoSmithKline Pharmaceuticals (Private) Limited", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_37609445", | |
"user": "Gilde Healthcare Partners B.V.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_566023", | |
"user": "Merck Capital Ventures, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_39421466", | |
"user": "Nomura Research and Advisory Co., Ltd., Investment Arm", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_313142805", | |
"user": "F-Prime Capital Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22471", | |
"user": "Polaris Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_50986297", | |
"user": "Stiefel Laboratories Pte Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_107247140", | |
"user": "Adherex, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_137345173", | |
"user": "Glaxo Kabushiki Kaisha", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_407691", | |
"user": "SoftBank Corp.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_3366199", | |
"user": "Five Prime Therapeutics, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "cb_agent_30bcdd65-41ce-122b-8ef3-52a187ed4bf9", | |
"user": "3i Group", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_98398", | |
"user": "Novartis Venture Funds", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_283398884", | |
"user": "TVM Life Science Management Inc", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_268795328", | |
"user": "Kuhs Gmbh", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_12916121", | |
"user": "Schering-Plough Farma Lda.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_99282905", | |
"user": "GlaxoSmithKline Healthcare ZAO", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_20905685", | |
"user": "OncoMed Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_28862297", | |
"user": "Societe Hospitaliere D'assurances Mutuelles", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "cbi_investor_Allergan", | |
"user": "Allergan", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_1828635", | |
"user": "Apple Tree Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_285225787", | |
"user": "Glaxosmithkline Intellectual Property Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_260139984", | |
"user": "Greylock Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_249798483", | |
"user": "Glaxosmithkline Intellectual Property Management Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_27204545", | |
"user": "GlaxoSmithKline Consumer Healthcare (Ireland) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_3451109", | |
"user": "Anacor Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_99360687", | |
"user": "GlaxoSmithKline Biologicals (Shanghai) Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_207220503", | |
"user": "Viiv Healthcare B.V.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_26934", | |
"user": "Connetics Corporation", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_23785", | |
"user": "The Vertical Group", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5522680", | |
"user": "Glaxo Wellcome Australia Pty Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_46280991", | |
"user": "Glaxosmithkline Consumer Healthcare - Produtos Para A SaUde E Higiene, Lda", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5449981", | |
"user": "Glaxosmithkline Consumer Healthcare B.V.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_2195628", | |
"user": "Biosynexus Incorporated", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_43032147", | |
"user": "Schering ZAO", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_6475685", | |
"user": "GlaxoSmithKline AG", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_20259", | |
"user": "EW Healthcare Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_163176399", | |
"user": "MSD France SAS", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_224919203", | |
"user": "GlaxoSmithKline Pharmaceuticals SA (Belgium)", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_11382917", | |
"user": "Roche Venture Fund", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_224097872", | |
"user": "Covidien LP", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_378744102", | |
"user": "Allen Pharmazeutika Gesellschaft m.b.H.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_540013415", | |
"user": "Allen\\u00A0& Hanburys Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_183320", | |
"user": "Aegis Analytical Corporation", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_22288431", | |
"user": "Clinical Data Management Centre India", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_22685", | |
"user": "Rho Capital Partners, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "cb_agent_e013830d-ccb9-100b-f890-e5999ab1a798", | |
"user": "Lux Capital", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_54334201", | |
"user": "Cellzome, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_6152031", | |
"user": "Glaxosmithkline Far East B.V.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_21115", | |
"user": "Institutional Venture Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_27244511", | |
"user": "Jafco Life Science Investment", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_7925479", | |
"user": "Franklin Templeton Distributors Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5472877", | |
"user": "GlaxoSmithKline Research & Development Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_1437158", | |
"user": "Manulife Capital", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_320400455", | |
"user": "Glaxosmithkline Consumer Healthcare (Overseas) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_419298", | |
"user": "Targacept, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_58090336", | |
"user": "Eskaylab Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_31231172", | |
"user": "Genocea Biosciences, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_3319053", | |
"user": "Mizuho Capital Co. Ltd.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_8121958", | |
"user": "SmithKline Beecham Holdings (UK) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_48965991", | |
"user": "GlaxoSmithKline Maroc S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_22515355", | |
"user": "GlaxoSmithKline S.p.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_109235325", | |
"user": "de Micl\\u00E9n a. s.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_437719", | |
"user": "Intel Capital", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22795", | |
"user": "SR One", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_379269524", | |
"user": "GlaxoSmithKline Consumer Healthcare Investments (Ireland) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_22555", | |
"user": "Prospect Venture Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_26763367", | |
"user": "Penn Labs Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_1259968", | |
"user": "Tolerx, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_101349", | |
"user": "Auriga Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_23626759", | |
"user": "GlaxoSmithKline S.A.E", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_251981971", | |
"user": "Sitari Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_20493", | |
"user": "Forward Ventures", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_848300", | |
"user": "Archemix Corp.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_34547545", | |
"user": "GlaxoSmithKline Trading Services Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_51048728", | |
"user": "Fondation Novartis Consumer Health Pour L'avancement Des Sciences Medicales, Biologiques E", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_36216801", | |
"user": "GlaxoSmithKline (China) Investment Co., Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_1716658", | |
"user": "Galapagos NV", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_272631271", | |
"user": "Thyritope Biosciences, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_874958", | |
"user": "GlaxoSmithKline Pakistan Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_139699718", | |
"user": "Windham Venture Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_123592", | |
"user": "De Novo Ventures", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_6866543", | |
"user": "GlaxoSmithKline South Africa (Pty) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_257087005", | |
"user": "GlaxoSmithKline Intellectual Property (No.2) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_374990110", | |
"user": "Mizuho Americas Llc", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_330559870", | |
"user": "GlaxoSmithKline Consumer Healthcare Korea Co., Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_50020859", | |
"user": "GlaxoSmithKline Costa Rica S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_20003", | |
"user": "Delphi Ventures", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_102785", | |
"user": "Aberdare Ventures", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_365138", | |
"user": "Alexandria Real Estate Equities, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5380511", | |
"user": "Catapult Ventures Group", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_21852166", | |
"user": "Oxford BioTherapeutics Ltd", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_269947725", | |
"user": "HIG LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22401249", | |
"user": "GlaxoSmithKline Biologicals Kft", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_379657478", | |
"user": "GlaxoSmithKline Consumer Healthcare Colombia SAS", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_9222269", | |
"user": "Inserm Transfert SA", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_24915409", | |
"user": "ID Biomedical Corporation Of Washington", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_304036794", | |
"user": "CadheRx Therapeutics, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "djvs_company_Care_Capital", | |
"user": "Care Capital", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_54413256", | |
"user": "GlaxoSmithKline Beteiligungs GmbH", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_34547539", | |
"user": "Glaxosmithkline Mackwood Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_60807854", | |
"user": "Allen Farmaceutica Sa", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_137562428", | |
"user": "Viiv Healthcare Srl", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_49406327", | |
"user": "GlaxoSmithKline Korea Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_132527437", | |
"user": "Glaxosmithkline Latvia Sia Sia", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_11420379", | |
"user": "Sirtris Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_23985", | |
"user": "Windamere Venture Partners, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_1827100", | |
"user": "Triple Point Technology, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_2708214", | |
"user": "MedImmune Ventures, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22153832", | |
"user": "NovaMin Technology, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_49406442", | |
"user": "GlaxoSmithKline (Thailand) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_111620672", | |
"user": "Uk Biobank Limited", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_8183093", | |
"user": "Setfirst (No. 2) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_112274800", | |
"user": "Smithkline Beecham Marketing And Technical Services Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_54082536", | |
"user": "Europharm S. A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_4788716", | |
"user": "Adage Capital Management, L.P.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_639038", | |
"user": "Union Fenosa e-business, S.L.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_32341661", | |
"user": "GlaxoSmithKline Asia Private Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_1716714", | |
"user": "Seahorse Bioscience, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_11215033", | |
"user": "Pfizer Venture Investments", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_146062695", | |
"user": "Glaxosmithkline Eood", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_23605", | |
"user": "TVM Capital GmbH", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_4223329", | |
"user": "Stiefel Laboratories, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_116189937", | |
"user": "Duncan Pharmaceuticals Philippines, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_24560022", | |
"user": "FLIR Systems Ltd.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_28186", | |
"user": "EPIX Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_1001491", | |
"user": "ChemoCentryx, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_108390443", | |
"user": "GlaxoSmithKline Kft", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_226140466", | |
"user": "GlaxoSmithKline (Tianjin) Co. Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_322217527", | |
"user": "GlaxoSmithKline Consumer Healthcare S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_4550716", | |
"user": "Valneva SE", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_721864", | |
"user": "Domantis Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_13290069", | |
"user": "Morningside Venture Capital", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_27526216", | |
"user": "Glaxo Wellcome Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_100410788", | |
"user": "Boehringer Ingelheim, Investment Arm", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_34967", | |
"user": "PPD Biomarker Discovery Sciences, LLC", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_23721", | |
"user": "Venrock", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_1716731", | |
"user": "Rock Maple Ventures", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_275442", | |
"user": "GlaxoSmithKline plc", | |
"description": "", | |
"color": "#ed1248", | |
"loaded": true, | |
"className": "Root" | |
}, | |
{ | |
"id": "ciq_company_115650", | |
"user": "OrbiMed Advisors, L.L.C.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_869685", | |
"user": "The Wellcome Foundation Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5468284", | |
"user": "Laboratoire GlaxoSmithKline", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_1340413", | |
"user": "Lafayette Equity, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_35643961", | |
"user": "GlycoVaxyn AG", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_49374894", | |
"user": "GSK Services Sp. z o.o.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_139621084", | |
"user": "Autifony Therapeutics Limited", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_1716736", | |
"user": "MIT Hub Angels", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_27902062", | |
"user": "Apposite Capital LLP", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_217348066", | |
"user": "Adechsa Gmbh", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_27060997", | |
"user": "Bill & Melinda Gates Foundation Asset Trust", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22981", | |
"user": "Skyline Ventures", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_11147403", | |
"user": "Mpex Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_37508090", | |
"user": "APEIRON Biologics AG", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_379275091", | |
"user": "GlaxoSmithKline Ecuador S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_3806202", | |
"user": "Sandlot Capital, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_13008734", | |
"user": "GlaxoSmithKline Holding AS", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_10600371", | |
"user": "MaxiNutrition Limited", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_54344222", | |
"user": "SB Holdings Capital Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5458365", | |
"user": "Glaxosmithkline Colombia, S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_26023713", | |
"user": "GlaxoSmithKline Australia Pty. Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_46949292", | |
"user": "GlaxoSmithKline Ilaclari Sanayi ve Ticaret A.S.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_145689957", | |
"user": "Stiefel Polska Sp Z O O - W Likwidacji", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5565409", | |
"user": "Baker Brothers Investments", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_1364613", | |
"user": "Touchstone Innovations Plc", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5534264", | |
"user": "GlaxoSmithKline B.V.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5663455", | |
"user": "GlaxoSmithKline Argentina S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_65052888", | |
"user": "Sterling Drug (Malaya) Sdn Berhad", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_525258", | |
"user": "Care Capital, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5673239", | |
"user": "GlaxoSmithKline Pharma GmbH", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_48760410", | |
"user": "GlaxoSmithKline Venezuela C.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_257195202", | |
"user": "GlaxoSmithKline International Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_426516939", | |
"user": "Skyline Capital Management, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_135238", | |
"user": "Ipsen S.A.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_49404582", | |
"user": "GlaxoSmithKline Pharmaceutical Sdn Bhd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_274198672", | |
"user": "Aspen Japan K.K.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_5755126", | |
"user": "GlaxoSmithKline Philippines Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_54237381", | |
"user": "GlaxoSmithKline (GSK) S.R.L.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_47285215", | |
"user": "Dealcyber Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_19305", | |
"user": "Adams Street Partners, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_22801085", | |
"user": "GlaxoSmithKline Manufacturing S.p.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_59373415", | |
"user": "UAB GlaxoSmithKline Lietuva", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_27058", | |
"user": "Corixa Corporation", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_4561775", | |
"user": "Hub Angels Investment Group, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_11354851", | |
"user": "Technogen Associates, LP", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_12058680", | |
"user": "QVT Financial LP", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5773520", | |
"user": "Medikit Co., Ltd.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5753918", | |
"user": "GlaxoSmithKline Dungarvan Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_214267307", | |
"user": "Glaxosmithkline Consumer Healthcare Srl", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5631139", | |
"user": "Stiefel Laboratories (Ireland) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_20525256", | |
"user": "Morningside Plaza", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_20386400", | |
"user": "Glaxo Wellcome Ceylon Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_33715", | |
"user": "Regeneron Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_3535279", | |
"user": "Nomura Securities International, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_25393861", | |
"user": "RP Sub No. 1, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_21766697", | |
"user": "Aileron Therapeutics, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_263582644", | |
"user": "GSK Pension Scheme", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "djvs_company_Konishi_Kiroshi", | |
"user": "Konishi Kiroshi", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_20515", | |
"user": "Frazier Healthcare Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "cb_agent_c40189cd-74f7-6f4a-884b-e8d2e2862d86", | |
"user": "Lux Capital", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_32365056", | |
"user": "SetPoint Medical Corporation", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_54339075", | |
"user": "Epizyme, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_98563207", | |
"user": "ViiV Healthcare Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_189488", | |
"user": "Bio-Techne Corporation", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_687130", | |
"user": "Sanofi", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_373593780", | |
"user": "Stiefel Laboratories Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_403699", | |
"user": "Manulife Financial Corporation", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5633110", | |
"user": "GlaxoSmithKline Sante Grand Public SAS", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_428072927", | |
"user": "Flare Corporation", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_282767950", | |
"user": "Viiv Healthcare Pty Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_30422995", | |
"user": "Smithkline Beecham Holdings (Australia) Pty Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_378743187", | |
"user": "Allen\\u00A0& Hanburys Pharmaceutical Nigeria Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_257026489", | |
"user": "Theravance Biopharma U.S., Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_1527221", | |
"user": "Latterell Venture Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "cbi_investor_Medikit_K_k", | |
"user": "Medikit K.k.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_139607094", | |
"user": "Beecham Group PLC", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_279414379", | |
"user": "Stiefel Research Australia Pty Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_304037120", | |
"user": "Calporta Therapeutics, Inc.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_320261761", | |
"user": "Brookside Capital, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "cb_agent_10b37c27-d4a9-e601-7fb1-4b9b67ed1297", | |
"user": "LigoCyte Pharmaceuticals", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_112205065", | |
"user": "Tempero Pharmaceuticals, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_380685449", | |
"user": "GlaxoSmithKline Consumer Healthcare Japan K.K.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_110676", | |
"user": "Scale Venture Partners", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_8176726", | |
"user": "Glaxo Wellcome International B.V.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_30423972", | |
"user": "GlaxoSmithKline Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_6490882", | |
"user": "Glaxosmithkline Oy", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_912002", | |
"user": "Future Capital AG", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_660915", | |
"user": "Wellcome Trust, Investment Division", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_49331421", | |
"user": "GlaxoSmithKline Holdings (One) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_1040458", | |
"user": "JCR Pharmaceuticals Co., Ltd.", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_23222672", | |
"user": "Beecham S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_12827277", | |
"user": "Glaxo Verwaltungs-Gmbh", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_272188828", | |
"user": "Action Potential Venture Capital Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_18533", | |
"user": "Abingworth LLP", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_54906809", | |
"user": "GlaxoSmithKline Trading ZAO", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5875106", | |
"user": "Glaxo Wellcome UK Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_39281078", | |
"user": "Glaxosmithkline Biologicals Manufacturing S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_204559232", | |
"user": "Stafford-Miller Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_254052522", | |
"user": "Auriga", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_379270720", | |
"user": "S.R. One International B.V.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_52097578", | |
"user": "GlaxoSmithKline Eesti OU", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_9770406", | |
"user": "Glaxo Wellcome Biofarma S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5472710", | |
"user": "Glaxo Wellcome Manufacturing Pte. Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_33329912", | |
"user": "Okairos AG", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_127425150", | |
"user": "SDSU-Brookings Federal Credit Union", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5886349", | |
"user": "SmithKline Beecham Pharma GmbH & Co KG", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_41018246", | |
"user": "Morningside Cyberventures Holdings, Ltd.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "cb_agent_bde5be40-84d3-6e44-b993-d22910c37589", | |
"user": "Rho Ventures", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_26840960", | |
"user": "Laboratoire Pharmaceutique Algerien Spa", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5408167", | |
"user": "N.V. Novartis Consumer Health S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_22135080", | |
"user": "Glaxo Finance Bermuda Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_22906056", | |
"user": "Glaxo AS", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_169393646", | |
"user": "Glaxo Wellcome Indonesia, PT", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_864120", | |
"user": "ID Biomedical Corporation of Quebec", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5479410", | |
"user": "GlaxoSmithKline K.K.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_23306888", | |
"user": "New Leaf Venture Partners, L.L.C.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_2689119", | |
"user": "Cycad Group, LLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_285299602", | |
"user": "Glaxosmithkline Investments (Ireland) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_540132427", | |
"user": "GSK Kazakhstan LLP", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5580057", | |
"user": "Kenso Kogyo K.k.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_29251489", | |
"user": "Oxford Capital Partners LLP", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_144339", | |
"user": "Westfield Capital Management Company, L.P.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_28395818", | |
"user": "Wellcome Trust Finance PLC", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_47167564", | |
"user": "Smithkline Beecham (pvt) Ltd", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_224441561", | |
"user": "GlaxoSmithKline Master Retirement Trust", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_22885653", | |
"user": "GlaxoSmithKline (Ireland) Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5874593", | |
"user": "Glaxo Operations UK Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_18511", | |
"user": "3i Group plc", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_5467355", | |
"user": "GlaxoSmithKline Export Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_244335951", | |
"user": "GlaxoSmithKline plc, Investment Arm", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_21925", | |
"user": "Morgenthaler", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_27115", | |
"user": "Coulter Pharmaceutical, Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_99222098", | |
"user": "ViiV Healthcare Trading Services UK Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_6466347", | |
"user": "GlaxoSmithKline Inc.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_47864389", | |
"user": "Smithkline Beecham Farma S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5527582", | |
"user": "SmithKline Beecham Pharma GmbH", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_25940031", | |
"user": "PLIVA Research Institute Ltd.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_54169956", | |
"user": "Gsk Vaccines Institute For Global Health Srl", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_90035850", | |
"user": "AstraZeneca Tika SNC", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_216313258", | |
"user": "Novartis Consumer Health Services S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_553785", | |
"user": "Bpifrance Investissement", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_115878072", | |
"user": "Nanjing MeiRui Pharma Co., Ltd.", | |
"description": "", | |
"color": "#2cb5ff", | |
"loaded": true, | |
"className": "JV/alliance" | |
}, | |
{ | |
"id": "ciq_company_249205", | |
"user": "Allergan, Inc.", | |
"description": "", | |
"color": "#ee2c2a", | |
"loaded": true, | |
"className": "Co-Investment" | |
}, | |
{ | |
"id": "ciq_company_99285754", | |
"user": "ViiV Healthcare Company", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5632209", | |
"user": "GlaxoSmithKline AB", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_236261493", | |
"user": "GlaxoSmithKline plc, Shareview Client", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_38924195", | |
"user": "Enigma Diagnostics Limited", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_22512384", | |
"user": "GlaxoSmithKline UK Limited", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_13538670", | |
"user": "elbion NV", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_233440665", | |
"user": "Nanjin Melrul Pharmaceutical Company", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_5491788", | |
"user": "Glaxosmithkline Biologicals S.A.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_262549448", | |
"user": "CRISPR Therapeutics AG", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_22288481", | |
"user": "Biomedical Data Sciences India", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_91092", | |
"user": "Pharmaceutical Product Development, LLC", | |
"description": "", | |
"color": "#fcb20f", | |
"loaded": true, | |
"className": "Investment" | |
}, | |
{ | |
"id": "ciq_company_39178253", | |
"user": "Affymax Technologies N.V.", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
}, | |
{ | |
"id": "ciq_company_41355134", | |
"user": "Novartis Consumer Health LLC", | |
"description": "", | |
"color": "#0ccaac", | |
"loaded": true, | |
"className": "Subsidiary" | |
} | |
] | |
} |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
<!DOCTYPE html> | |
<html> | |
<head> | |
<meta charset="utf-8"> | |
<title></title> | |
<link rel="stylesheet" type="text/css" href="styles.css"> | |
<script src="https://d3js.org/d3.v4.min.js"></script> | |
</head> | |
<body> | |
<div id="main-wrapper"> | |
<div id="chart"></div> | |
<div id="sidebar"> | |
<div id="current-date"> | |
<div id="month-display">Month</div> | |
<div id="day-display">Day</div> | |
<div id="year-display">Year</div> | |
</div> | |
<div id="play"> | |
<div class="playbutton">pause</div> | |
</div> | |
<div id="speed"> | |
<div class="togglebutton slow current" data-speed="slow">slow</div> | |
<div class="togglebutton medium" data-speed="medium">medium</div> | |
<div class="togglebutton fast" data-speed="fast">fast</div> | |
<div class="clr"></div> | |
</div> | |
<div id="node-names"></div> | |
</div> | |
</div> | |
<script src="index.js"></script> | |
</body> | |
</html> |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
var width = 780, | |
height = 800, | |
radiusLabelCircle = Math.min(width, height) / 2 * 0.9, | |
radiusClusterCircle = Math.min(width, height) / 2 * 0.7; | |
var circleRadius = 3; | |
var circleDefaultColor = "#bbb"; | |
var nodes, clusters = []; | |
var circle; | |
var currentTime = 0; // current time 1 unit denotes 1 day | |
var endTime; // The final date convereted to currentTime unit | |
var startDate, endDate; | |
var monthNames = ["January", | |
"February", | |
"March", | |
"April", | |
"May", | |
"June", | |
"July", | |
"August", | |
"September", | |
"October", | |
"November", | |
"December"]; | |
var timeout; | |
var userSpeed = "slow"; | |
var userPlay = "pause"; | |
var speeds = { "slow": 1000, "medium": 200, "fast": 50 }; | |
var alpha = 0.25; // force simulation alpha target for smooth animation | |
var simulation = d3.forceSimulation() | |
.velocityDecay(0.6) | |
.alphaDecay(0.04) | |
.force("x", d3.forceX().strength(0.025).x(getClusterX)) | |
.force("y", d3.forceY().strength(0.025).y(getClusterY)) | |
.force("collision", d3.forceCollide().radius(circleRadius + 0.25).iterations(5)) | |
.on("tick", ticked); | |
simulation.stop(); | |
var svg = d3.select("#chart").append("svg") | |
.attr("width", width) | |
.attr("height", height); | |
d3.json("demoOverTime.json", function(error, data) { | |
if (error) throw error; | |
nodes = data.nodes; | |
// Outer circle and cetner clusters to categorize transactions | |
var clusterNames = d3.set(nodes, function(d) { return d.className; }).values(); | |
var theta = 2 * Math.PI / (clusterNames.length); | |
clusterNames.forEach(function(clusterName, i) { | |
clusters.push({ | |
index: i + 1, | |
name: clusterName, | |
xLabel: radiusLabelCircle * Math.cos(i * theta) + width / 2, | |
yLabel: radiusLabelCircle * Math.sin(i * theta) + height / 2, | |
x: radiusClusterCircle * Math.cos(i * theta) + width / 2, | |
y: radiusClusterCircle * Math.sin(i * theta) + height / 2, | |
count: 0 | |
}); | |
}); | |
clusters.unshift({ | |
index: 0, | |
name: "All Transactions", | |
xLabel: width / 2, | |
yLabel: height / 2, | |
x: width / 2, | |
y: height / 2, | |
count: nodes.length | |
}); | |
// Add random dates to nodes | |
startDate = new Date("2018-01-01"); | |
endDate = new Date("2018-02-28"); | |
var positionScale = d3.scaleLinear() | |
.domain([0, Math.round((endDate - startDate) / (1000*60*60*24))]) | |
.range([Math.sqrt(nodes.length * circleRadius), 0]); | |
nodes.forEach(function(d) { | |
d.date = new Date(+startDate + Math.random() * (endDate - startDate)); | |
d.dateDiff = Math.round((d.date - startDate) / (1000*60*60*24)); // Time for the node moves to its cluster | |
d.fillColor = circleDefaultColor; | |
d.cluster = "All Transactions"; | |
var r = positionScale(d.dateDiff); | |
var thetaNode = (clusterNames.indexOf(d.className) + Math.random() - 0.5) * theta ; | |
d.x = width / 2 + r * Math.cos(thetaNode); | |
d.y = height / 2 + r * Math.sin(thetaNode); | |
}); | |
endTime = d3.max(nodes, function(d) { return d.dateDiff; }); | |
circle = svg.selectAll(".node") | |
.data(nodes) | |
.enter().append("circle") | |
.attr("class", "node") | |
.attr("r", circleRadius) | |
.style("fill", function(d) { return d.fillColor; }); | |
// Cluster labels | |
var labelG = svg.selectAll(".cluster-label-g") | |
.data(clusters) | |
.enter().append("g") | |
.attr("class", "cluster-label-g") | |
.attr("transform", function(d) { | |
return "translate(" + d.xLabel + "," + d.yLabel + ")"; | |
}); | |
labelG.append("text") | |
.attr("class", "cluster-label") | |
.attr("text-anchor", "middle") | |
.text(function(d) { return d.name; }); | |
labelG.append("text") | |
.attr("class", "cluster-node-count") | |
.attr("text-anchor", "middle") | |
.attr("dy", "1.3em") | |
.text(function(d) { return d.count; }); | |
// Play toggle | |
d3.select(".playbutton") | |
.on("click", function() { | |
if (userPlay === "pause") { | |
userPlay = "play"; | |
simulation.stop(); | |
clearTimeout(timeout); | |
} else if (userPlay === "play") { | |
userPlay = "pause"; | |
simulation.alpha(alpha).alphaTarget(alpha).restart(); | |
timeout = setTimeout(timer, speeds[userSpeed]); | |
} | |
d3.select(".playbutton").text(userPlay); | |
}); | |
// Speed toggle | |
d3.selectAll(".togglebutton") | |
.on("click", function() { | |
userSpeed = this.dataset.speed; | |
if (userSpeed === "slow") { | |
d3.select(".slow").classed("current", true); | |
d3.select(".medium").classed("current", false); | |
d3.select(".fast").classed("current", false); | |
} else if (userSpeed === "medium") { | |
d3.select(".slow").classed("current", false); | |
d3.select(".medium").classed("current", true); | |
d3.select(".fast").classed("current", false); | |
} else { | |
d3.select(".slow").classed("current", false); | |
d3.select(".medium").classed("current", false); | |
d3.select(".fast").classed("current", true); | |
} | |
}); | |
simulation.nodes(nodes); | |
simulation.alphaTarget(alpha).restart(); | |
timeout = setTimeout(timer, speeds[userSpeed]); | |
}); | |
function timer() { | |
var nodeNames = []; | |
nodes.forEach(function(d) { | |
// Move the node to its cluster | |
if (d.dateDiff === currentTime) { | |
var cluster = clusters.find(function(c) { return c.name === d.className; }); | |
// Update cluster so the circle starts to move towards outer cluter | |
d.cluster = cluster.name; | |
// Update cluster nodes count | |
cluster.count += 1; | |
clusters[0].count -= 1; | |
// Update circle color | |
d.fillColor = d.color; | |
// Append the current node name to nodeNames | |
nodeNames.push(d.user); | |
} | |
}); | |
simulation | |
.force("x", d3.forceX().strength(getStrength).x(getClusterX)) | |
.force("y", d3.forceY().strength(getStrength).y(getClusterY)); | |
// Update date display | |
var currentDate = new Date(currentTime * (1000*60*60*24) + startDate.getTime()); | |
d3.select("#month-display").text(monthNames[currentDate.getMonth()]); | |
d3.select("#day-display").text(currentDate.getDate()); | |
d3.select("#year-display").text(currentDate.getFullYear()); | |
// Update node names for current date | |
var nodeNamesUpdate = d3.select("#node-names") | |
.selectAll(".node-name") | |
.data(nodeNames); | |
nodeNamesUpdate.exit().remove(); | |
nodeNamesUpdate.enter().append("div") | |
.attr("class", "node-name") | |
.merge(nodeNamesUpdate) | |
.text(function(d) { return d; }); | |
// Update cluster node count | |
svg.selectAll(".cluster-node-count") | |
.text(function(d) { return d.count; }); | |
simulation.restart(); | |
if (currentTime < endTime) { | |
timeout = setTimeout(timer, speeds[userSpeed]); | |
} else if (currentTime === endTime) { | |
userPlay = "the end"; | |
d3.select(".playbutton").text(userPlay); | |
} | |
currentTime += 1; | |
} | |
function ticked() { | |
circle | |
.attr("cx", function(d) { return d.x; }) | |
.attr("cy", function(d) { return d.y; }) | |
.style("fill", function(d) { return d.fillColor; }); | |
} | |
function getStrength(d) { | |
return d.cluster === "All Transactions" ? 0.005 : 0.05; | |
} | |
function getClusterX(d) { | |
return clusters.find(function(c) { return c.name === d.cluster; }).x; | |
} | |
function getClusterY(d) { | |
return clusters.find(function(c) { return c.name === d.cluster; }).y; | |
} |
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
#main-wrapper { | |
font-family: sans-serif; | |
font-size:13px; | |
width:1090px; | |
} | |
#sidebar { | |
width:259px; | |
float:left; | |
margin-left:20px; | |
padding-left:20px; | |
border-left: 1px solid #ccc; | |
height:800px; | |
} | |
#current-date { | |
font-size:42px; | |
color:#666; | |
text-align:center; | |
} | |
#chart { | |
float:left; | |
} | |
#speed, | |
#play { | |
font-size:13px; | |
text-transform:uppercase; | |
margin:15px 0 20px 25px; | |
} | |
#play .playbutton { | |
padding:9px 3px; | |
margin-bottom: 10px; | |
text-align:center; | |
border:1px solid #ccc; | |
cursor:pointer; | |
float:left; | |
width:195px; | |
} | |
#speed .togglebutton { | |
padding:3px 3px; | |
text-align:center; | |
border:1px solid #ccc; | |
cursor:pointer; | |
float:left; | |
width:60px; | |
} | |
#speed .togglebutton.slow { | |
border-right:none; | |
} | |
#speed .togglebutton.fast { | |
border-left:none; | |
} | |
#speed .togglebutton.current { | |
color:#fff; | |
background:#000; | |
border:1px solid #000; | |
} | |
#node-names { | |
clear: both; | |
padding: 10px 24px; | |
line-height:1.1em; | |
} | |
.node-name { | |
padding: 4px 0px; | |
} | |
.cluster-label, | |
.cluster-node-count { | |
text-shadow: 0px 2px #fff, 0px -2px #fff, 2px 0px #fff, -2px 0px #fff | |
} | |
/*.line{ | |
stroke-width:0.1px; | |
} | |
.clr { | |
clear:both; | |
}*/ | |
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment